Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral GLP-1 and PYY3-36 for Inhibition of Food Intake
NCT00822705Phase 2Completed
- Sponsor
- University Hospital Basel
- Start
- Aug 2008
- Primary completion
- Nov 2008
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Glucagon-like peptide 1, peptide YY 3-36 in obesity, sponsored by University Hospital Basel. Started Aug 2008; status: completed.
02
Drugs
Glucagon-like peptide 1peptide YY 3-36
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00822705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00822705.